These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1152 related items for PubMed ID: 11083266

  • 1. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD, Medsger TA.
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [Abstract] [Full Text] [Related]

  • 2. Changes in causes of death in systemic sclerosis, 1972-2002.
    Steen VD, Medsger TA.
    Ann Rheum Dis; 2007 Jul; 66(7):940-4. PubMed ID: 17329309
    [Abstract] [Full Text] [Related]

  • 3. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H, Lucas M, Fertig N, Medsger TA.
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.
    Sacks DG, Okano Y, Steen VD, Curtiss E, Shapiro LS, Medsger TA.
    J Rheumatol; 1996 Apr; 23(4):639-42. PubMed ID: 8730118
    [Abstract] [Full Text] [Related]

  • 6. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF, Pope JE, Ouimet JM.
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [Abstract] [Full Text] [Related]

  • 7. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA.
    Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
    [Abstract] [Full Text] [Related]

  • 8. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P.
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [Abstract] [Full Text] [Related]

  • 9. Survival and causes of death in 366 Hungarian patients with systemic sclerosis.
    Czirják L, Kumánovics G, Varjú C, Nagy Z, Pákozdi A, Szekanecz Z, Szucs G.
    Ann Rheum Dis; 2008 Jan; 67(1):59-63. PubMed ID: 17519276
    [Abstract] [Full Text] [Related]

  • 10. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model.
    Shand L, Lunt M, Nihtyanova S, Hoseini M, Silman A, Black CM, Denton CP.
    Arthritis Rheum; 2007 Jul; 56(7):2422-31. PubMed ID: 17599771
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature.
    Jaovisidha K, Csuka ME, Almagro UA, Soergel KH.
    Semin Arthritis Rheum; 2005 Feb; 34(4):689-702. PubMed ID: 15692963
    [Abstract] [Full Text] [Related]

  • 13. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
    Nihtyanova SI, Tang EC, Coghlan JG, Wells AU, Black CM, Denton CP.
    QJM; 2010 Feb; 103(2):109-15. PubMed ID: 19966313
    [Abstract] [Full Text] [Related]

  • 14. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S, Harding S, Bonner A, Zummer B, Baron M, Pope J, Canadian Scleroderma Research Group.
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Localized scleroderma in childhood is not just a skin disease.
    Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, Espada G, Corona F, Mukamel M, Vesely R, Musiej-Nowakowska E, Chaitow J, Ros J, Apaz MT, Gerloni V, Mazur-Zielinska H, Nielsen S, Ullman S, Horneff G, Wouters C, Martini G, Cimaz R, Laxer R, Athreya BH, Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society (PRES).
    Arthritis Rheum; 2005 Sep; 52(9):2873-81. PubMed ID: 16142730
    [Abstract] [Full Text] [Related]

  • 17. Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation.
    Clements PJ, Furst DE.
    J Rheumatol Suppl; 1997 May; 48():85-8. PubMed ID: 9150125
    [Abstract] [Full Text] [Related]

  • 18. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.
    Joven BE, Almodovar R, Carmona L, Carreira PE.
    Semin Arthritis Rheum; 2010 Feb; 39(4):285-93. PubMed ID: 19782387
    [Abstract] [Full Text] [Related]

  • 19. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A, Bellissimo S, Scotto di Uccio F, Vigorito F, Moscato F, Tozzi N, Di Donato M, Citro R, Stisi S, Scherillo M.
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [Abstract] [Full Text] [Related]

  • 20. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
    Hanitsch LG, Burmester GR, Witt C, Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, Müller-Ladner U, Schulze-Lohoff E, Becker M, Sunderkoetter C, DNSS centers, Riemekasten G.
    Rheumatology (Oxford); 2009 Jan; 48(1):70-3. PubMed ID: 19056798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.